Head and Neck Low Grade Chondrosarcoma—A Rare Entity
Chondrosarcoma represents approximately 0.1% of all neoplasms of the head and neck and is considered a rare disease with a relatively good prognosis. The 5-year overall survival (OS) rate is estimated at 70–80%, being considered a disease with a low growth rate. Approximately 13% of all cases of cho...
Main Authors: | Camil Ciprian Mireștean, Cristiana Eugenia Simionescu, Roxana Irina Iancu, Mihai Cosmin Stan, Dragoș Petru Teodor Iancu, Florinel Bădulescu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-09-01
|
Series: | Diagnostics |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4418/13/19/3026 |
Similar Items
-
The Prognostic Value of Platelet–Lymphocyte Ratio, Neutrophil–Lymphocyte Ratio, and Monocyte–Lymphocyte Ratio in Head and Neck Squamous Cell Carcinoma (HNSCC)—A Retrospective Single Center Study and a Literature Review
by: Camil Ciprian Mireștean, et al.
Published: (2023-11-01) -
Skin Cancers of the Head and Neck Region: the Real World Epidemiological and Therapeutic Data from the Cancer Registry of Dolj County
by: Camil Ciprian MIRESTEAN, et al.
Published: (2023-09-01) -
New horizons in modulating the radio-sensitivity of head and neck cancer - 100 years after Warburg’ effect discovery
by: Camil Ciprian Mireștean, et al.
Published: (2022-12-01) -
Micro-RNAs, the Cornerstones of the Future of Radiobiology in Head and Neck Cancers?
by: Camil Ciprian Mireștean, et al.
Published: (2022-02-01) -
Capecitabine—A “Permanent Mission” in Head and Neck Cancers “War Council”?
by: Camil Ciprian Mireștean, et al.
Published: (2022-09-01)